Sign in
Author
|
Conference
|
Journal
|
Organization
|
Year
|
DOI
Look for results that meet for the following criteria:
since
equal to
before
between
and
Search in all fields of study
Limit my searches in the following fields of study
Agriculture Science
Arts & Humanities
Biology
Chemistry
Computer Science
Economics & Business
Engineering
Environmental Sciences
Geosciences
Material Science
Mathematics
Medicine
Physics
Social Science
Multidisciplinary
Co-authors
(941)
Sabina A. Murphy
166
Eugene Braunwald
126
Christopher P. Cannon
123
Elliott M. Antman
91
David A. Morrow
64
Conferences
(1)
SOFE
1
Journals
(48)
AMER J CARDIOL
68
J AMER COLL CARDIOL
68
AMER HEART J
51
J THROMB THROMBOLYSIS
28
CATHETER CARDIOVASC INTERV
9
Keywords
(353)
Embed
Subscribe
Academic
Authors
C. Michael Gibson
C. Michael Gibson,Beth Israel Deaconess Medical Center,Cardiology,Pharmacology,Anatomy
Edit
C. Michael Gibson
Beth Israel Deaconess Medical Center
Publications:
381
|
Citations:
7661
Fields:
Cardiology
,
Pharmacology
,
Anatomy
View FAQ about top research areas and Fields of study
Collaborated with
941 co-authors
from 1988 to 2011
|
Cited by
16701 authors
Cumulative
Annual
Sort by:
Publications
(381)
BibTeX
|
RIS
|
RefWorks
Download
Hospital Delays in Reperfusion for ST-Elevation Myocardial Infarction Implications When Selecting a Reperfusion Strategy
(
Citations: 69
)
Duane S. Pinto
,
Ajay J. Kirtane
,
Brahmajee K. Nallamothu
,
Sabina A. Murphy
,
David J. Cohen
,
Roger J. Laham
,
Donald E. Cutlip
,
Eric R. Bates
,
Paul D. Frederick
,
Dave P. Miller
,
Joseph P. Carrozza
,
Elliott M. Antman
C. Michael Gibson
http://academic.research.microsoft.com/io.ashx?type=5&id=11648414&selfId1=3097905&selfId2=0&maxNumber=12&query=
Published in 2011.
Rationale and design of the Anti-Xa Therapy to Lower cardiovascular events in Addition to standard therapy in Subjects with Acute Coronary Syndrome–Thrombolysis in Myocardial Infarction 51 (ATLAS-ACS 2 TIMI 51) trial: A randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of rivaroxaban in subjects with acute coronary syndrome
(
Citations: 4
)
C. Michael Gibson
,
Jessica L. Mega
,
Paul Burton
,
Shinya Goto
,
Freek Verheugt
,
Christoph Bode
,
Alexei Plotnikov
,
Xiang Sun
,
Nancy Cook-Bruns
,
Eugene Braunwald
Journal:
American Heart Journal - AMER HEART J
, vol. 161, no. 5, pp. 815-821.e6, 2011
RISK FACTORS ASCERTAINED AT PRESENTATION AND MORTALITY AMONG PATIENTS WITH FIRST MYOCARDIAL INFARCTION
John G. Canto
,
Catarina I. Kiefe
,
William J. Rogers
,
Eric D. Peterson
,
Paul D. Frederick
,
William J. French
,
C. Michael Gibson
,
Charles V. Pollack
,
Joseph P. Ornato
,
Costas G. Lambrew
,
Robert J. Zalenski
,
Jan Penney
http://academic.research.microsoft.com/io.ashx?type=5&id=49386899&selfId1=3097905&selfId2=0&maxNumber=12&query=
Journal:
Journal of The American College of Cardiology - J AMER COLL CARDIOL
, vol. 57, no. 14, pp. E1037-E1037, 2011
ANGIOGRAPHIC OUTCOMES IN THE PLATELET INHIBITION AND PATIENT OUTCOMES (PLATO) TRIAL
Vijayalakshmi Kunadian
,
Cafer Zorkun
,
Stefan James
,
Jinhui Wu
,
Atif Muhammad
,
Robert Storey
,
Ph Gabriel Steg
,
Hugo Katus
,
Håkan Emanuelsson
,
Jay Horrow
,
Juan Maya
,
Lars Wallentin
C. Michael Gibson
http://academic.research.microsoft.com/io.ashx?type=5&id=49386808&selfId1=3097905&selfId2=0&maxNumber=12&query=
Journal:
Journal of The American College of Cardiology - J AMER COLL CARDIOL
, vol. 57, no. 14, pp. E946-E946, 2011
AS004 Dynamic Change Of Wall Shear Stress After Stenting Bifurcation Lesions: Subgroup Analysis From DKCRUSH-II Trial
S. Chen
,
C. M. Gibson
,
J. Kan
,
J. J. Zhang
,
Z. Y. Hu
,
H. Xu
,
T. Xu
,
F. Ye
,
N. L. Tian
,
J. X. Zhang
,
Z. Z. Liu
Journal:
American Journal of Cardiology - AMER J CARDIOL
, vol. 107, no. 8, pp. 2A-2A, 2011
Sort by:
Citations
(7661 times by 5381 publications)
Predicting Clopidogrel Response Using DNA Samples Linked to an Electronic Health Record
J T Delaney
,
A H Ramirez
,
E Bowton
,
J M Pulley
,
M A Basford
,
J S Schildcrout
,
Y Shi
,
R Zink
,
M Oetjens
,
H Xu
,
J H Cleator
,
E Jahangir
http://academic.research.microsoft.com/io.ashx?type=5&id=56546969&selfId1=3097905&selfId2=0&maxNumber=12&query=
Journal:
Clinical Pharmacology & Therapeutics - CLIN PHARMACOL THER
, vol. 91, no. 2, pp. 257-263, 2012
Clinical Trial Educator program – a novel approach to accelerate enrollment in a phase III International Acute Coronary Syndrome Trial
Brigitte Kendall
,
Reto Städeli
,
Belinda Schegg
,
Martin Olbrich
,
Edmond Chen
,
Rona Harmelin-Kadouri
,
Peter Aurup
,
Tilmann Schwab
,
Steven K Hildemann
Journal:
Clinical Trials - CLIN TRIALS
, vol. 9, no. 3, pp. 358-366, 2012
Relationship Between Exposure to Prasugrel Active Metabolite and Clinical Outcomes in the TRITON-TIMI 38 Substudy
Jeffrey S. Riesmeyer
,
Daniel E. Salazar
,
Govinda J. Weerakkody
,
Lan Ni
,
Rebecca E. Wrishko
,
C. Steven Ernest
,
Junxiang Luo
,
Ying G. Li
,
David S. Small
,
Shashank Rohatagi
,
William L. Macias
Journal:
Journal of Clinical Pharmacology - J CLIN PHARMACOL
, vol. 52, no. 6, pp. 789-797, 2012
Shift From Surrogate End Point to Outcome Trials: Implications for Cardiovascular Safety Assessment in Development Programs for Antidiabetic Drugs
J F Marcinak
,
P Viswanathan
,
V Arora
,
L E Roebel
,
T R Strack
,
E Leifke
Journal:
Clinical Pharmacology & Therapeutics - CLIN PHARMACOL THER
, vol. 91, no. 3, pp. 514-520, 2012
STEMI mortality in community hospitals versus PCI-capable hospitals: results from a nationwide STEMI network programme
Marc J Claeys
,
Peter R Sinnaeve
,
Carl Convens
,
Philippe Dubois
,
Jean Boland
,
Pascal Vranckx
,
Sofie Gevaert
,
Antoine de Meester
,
Patrick Coussement
,
Herbert De Raedt
,
Christophe Beauloye
,
Marc Renard
http://academic.research.microsoft.com/io.ashx?type=5&id=57116326&selfId1=3097905&selfId2=0&maxNumber=12&query=
Published in 2012.
Comments